• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Skyepharma PLC

+ Add to Watchlist

SKP:LN

319.000 GBp 10.250 3.11%

As of 11:35:26 ET on 10/01/2014.

Snapshot for Skyepharma PLC (SKP)

Open: 320.000 Day's Range: 317.250 - 328.500 Volume: 79,174
Previous Close: 329.250 52wk Range: 74.567 - 334.750 1-Yr Rtn: +267.15%

Stock Chart for SKP

No chart data available.
  • SKP:LN 319.000
  • 1D
  • 1M
  • 1Y
329.250
Interactive SKP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.8137
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.2221
Est. EPS (GBP) (12/2014) 0.1610
Est. PEG Ratio -
Market Cap (M GBP) 334.35
Shares Outstanding (M) 104.81
30 Day Average Volume 649,394
Price/Book (mrq) 14.7943
Price/Sale (ttm) 2.8323
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKP

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SKP

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter William GrantChief Executive OfficerAndrew DerodraChief Financial Officer
John MurphySecretary/General Counsel
More Company Profile & Key Executives for SKP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil